Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023890 (
cirrhosis
)
42,195
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Glycosyl-phosphatidylinositol (GPI) anchor attachment protein 1 (
GPAA1
) transcript level was frequently up-regulated in our earlier study on gene expression profile. We therefore analyzed the potential involvement of
GPAA1
in hepatocellular carcinoma (HCC) as
GPAA1
gene locates at chromosome 8q24.3 which chromosome region is frequently amplified in HCCs. In this study, we observed that
GPAA1
transcript in the HCCs (n = 93) showed a significantly higher expression level compared with their paralleled adjacent nontumor liver tissues,
cirrhosis
(n = 15) and normal (n = 16) liver tissues using real-time quantitative RT-PCR (p < 0.005). We also demonstrated that
GPAA1 protein
up-regulation was common in HCCs (90%, 9/10), and
GPAA1
gene was frequently amplified (73%, 11/15) using quantitative microsatellite analysis. Increased
GPAA1
expression was significantly associated with HCCs poor cellular differentiation (p = 0.011) and poor prognosis (p = 0.010). We then modulated the
GPAA1
expression level in HCC cells (Hep3B) by transfection experiments, which was shown to positively regulate cell adhesion ability (p = 0.004) and proliferation rate (p = 0.037). Our data revealed
GPAA1
gene amplification with overexpression of RNA and protein in HCC.
GPAA1
is a potential amplification target of chromosome 8q and responsible to regulate tumor cells behavior.
...
PMID:Increased expression of glycosyl-phosphatidylinositol anchor attachment protein 1 (GPAA1) is associated with gene amplification in hepatocellular carcinoma. 1664 71